• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Anoctamin 1 通过将 Cl 通道激活与 RANKL-RANK 信号转导偶联来控制骨吸收。

Anoctamin 1 controls bone resorption by coupling Cl channel activation with RANKL-RANK signaling transduction.

机构信息

State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, 100094, Beijing, China.

Key Laboratory of Molecular Biophysics, Hebei Province, Institute of Biophysics, School of Health Sciences and Biomedical Engineering, Hebei University of Technology, 300401, Tianjin, China.

出版信息

Nat Commun. 2022 May 24;13(1):2899. doi: 10.1038/s41467-022-30625-9.

DOI:10.1038/s41467-022-30625-9
PMID:35610255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9130328/
Abstract

Osteoclast over-activation leads to bone loss and chloride homeostasis is fundamental importance for osteoclast function. The calcium-activated chloride channel Anoctamin 1 (also known as TMEM16A) is an important chloride channel involved in many physiological processes. However, its role in osteoclast remains unresolved. Here, we identified the existence of Anoctamin 1 in osteoclast and show that its expression positively correlates with osteoclast activity. Osteoclast-specific Anoctamin 1 knockout mice exhibit increased bone mass and decreased bone resorption. Mechanistically, Anoctamin 1 deletion increases intracellular Cl concentration, decreases H secretion and reduces bone resorption. Notably, Anoctamin 1 physically interacts with RANK and this interaction is dependent upon Anoctamin 1 channel activity, jointly promoting RANKL-induced downstream signaling pathways. Anoctamin 1 protein levels are substantially increased in osteoporosis patients and this closely correlates with osteoclast activity. Finally, Anoctamin 1 deletion significantly alleviates ovariectomy induced osteoporosis. These results collectively establish Anoctamin 1 as an essential regulator in osteoclast function and suggest a potential therapeutic target for osteoporosis.

摘要

破骨细胞过度激活会导致骨质流失,而氯离子稳态对破骨细胞功能至关重要。钙激活氯离子通道 Aniodamin 1(也称为 TMEM16A)是一种参与许多生理过程的重要氯离子通道。然而,其在破骨细胞中的作用仍未得到解决。在这里,我们鉴定出破骨细胞中存在 Aniodamin 1,并表明其表达与破骨细胞活性呈正相关。破骨细胞特异性敲除 Aniodamin 1 的小鼠表现出骨量增加和骨吸收减少。机制上,Aniodamin 1 缺失会增加细胞内 Cl 浓度,减少 H 分泌并减少骨吸收。值得注意的是,Aniodamin 1 与 RANK 发生物理相互作用,这种相互作用依赖于 Aniodamin 1 通道活性,共同促进 RANKL 诱导的下游信号通路。骨质疏松症患者的 Aniodamin 1 蛋白水平显著增加,这与破骨细胞活性密切相关。最后,Aniodamin 1 缺失显著缓解卵巢切除诱导的骨质疏松症。这些结果共同确立了 Aniodamin 1 作为破骨细胞功能的重要调节剂,并为骨质疏松症提供了一个潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/2c61de33ccab/41467_2022_30625_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/c122b9016a98/41467_2022_30625_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/4ff7c7adcb93/41467_2022_30625_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/a09d20981917/41467_2022_30625_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/32e289cc2edb/41467_2022_30625_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/f4eca14fcaed/41467_2022_30625_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/7e72d965d683/41467_2022_30625_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/2c61de33ccab/41467_2022_30625_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/c122b9016a98/41467_2022_30625_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/4ff7c7adcb93/41467_2022_30625_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/a09d20981917/41467_2022_30625_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/32e289cc2edb/41467_2022_30625_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/f4eca14fcaed/41467_2022_30625_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/7e72d965d683/41467_2022_30625_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8380/9130328/2c61de33ccab/41467_2022_30625_Fig7_HTML.jpg

相似文献

1
Anoctamin 1 controls bone resorption by coupling Cl channel activation with RANKL-RANK signaling transduction.Anoctamin 1 通过将 Cl 通道激活与 RANKL-RANK 信号转导偶联来控制骨吸收。
Nat Commun. 2022 May 24;13(1):2899. doi: 10.1038/s41467-022-30625-9.
2
Onc201 reduces osteoclastogenesis and prevents ovariectomy-induced bone loss via inhibiting RANKL-induced NFATc1 activation and the integrin signaling pathway.Onc201通过抑制RANKL诱导的NFATc1激活和整合素信号通路来减少破骨细胞生成,并预防卵巢切除诱导的骨质流失。
Eur J Pharmacol. 2022 May 15;923:174908. doi: 10.1016/j.ejphar.2022.174908. Epub 2022 Apr 9.
3
Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.牛蒡苷通过抑制 RANKL 诱导的 ROS 和 NFATc1 激活来阻断破骨细胞生成和骨吸收。
Pharmacol Res. 2020 Sep;159:104944. doi: 10.1016/j.phrs.2020.104944. Epub 2020 May 23.
4
PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.PDK1 是 RANKL 诱导的破骨细胞形成和功能的重要脂质激酶,通过调节 Akt-GSK3β-NFATc1 信号级联。
J Cell Biochem. 2020 Nov;121(11):4542-4557. doi: 10.1002/jcb.29677. Epub 2020 Feb 12.
5
Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.佛手柑内酯通过抑制 NF-κB 和 JNK 信号通路抑制 RANKL 诱导的破骨细胞生成和卵巢切除诱导的骨质疏松症。
Biochem Biophys Res Commun. 2019 Feb 5;509(2):329-334. doi: 10.1016/j.bbrc.2018.12.112. Epub 2018 Dec 20.
6
Ca-activated chloride channel ANO1: A new regulator of osteoclast function.钙激活氯离子通道 ANO1:破骨细胞功能的新调节因子。
Cell Calcium. 2022 Sep;106:102633. doi: 10.1016/j.ceca.2022.102633. Epub 2022 Jul 16.
7
(-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways.(-)-表儿茶素3-O-β-D-阿洛吡喃糖苷通过抑制核因子κB受体活化因子配体(RANKL)诱导的核因子κB(NF-κB)和活化T细胞核因子c1(NFATc-1)信号通路,预防去卵巢诱导的小鼠骨质流失。
BMC Complement Altern Med. 2017 May 3;17(1):245. doi: 10.1186/s12906-017-1737-9.
8
Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.芫花素 B 通过抑制 NFATc1 和 ROS 活性抑制 RANKL 诱导的破骨细胞生成和去卵巢骨质疏松症。
Theranostics. 2019 Jul 3;9(16):4648-4662. doi: 10.7150/thno.35414. eCollection 2019.
9
Cajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL-induced signaling pathways.兵豆素通过抑制破骨细胞形成和 RANKL 诱导的信号通路抑制骨质疏松症。
J Cell Physiol. 2019 Jul;234(7):11792-11804. doi: 10.1002/jcp.27868. Epub 2018 Dec 4.
10
Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathways.罗布酸通过靶向RANKL诱导的细胞内信号通路来减轻破骨细胞生成和骨吸收。
J Cell Physiol. 2022 Mar;237(3):1790-1803. doi: 10.1002/jcp.30642. Epub 2021 Nov 19.

引用本文的文献

1
Antioxidant scaffolds for enhanced bone regeneration: recent advances and challenges.用于增强骨再生的抗氧化支架:最新进展与挑战
Biomed Eng Online. 2025 Apr 8;24(1):41. doi: 10.1186/s12938-025-01370-z.
2
Tamsulosin ameliorates bone loss by inhibiting the release of Cl through wedging into an allosteric site of TMEM16A.坦索罗辛通过楔入TMEM16A的变构位点抑制氯离子释放,从而改善骨质流失。
Proc Natl Acad Sci U S A. 2025 Jan 7;122(1):e2407493121. doi: 10.1073/pnas.2407493121. Epub 2024 Dec 31.
3
Tunable Cytosolic Chloride Indicators for Real-Time Chloride Imaging in Live Cells.

本文引用的文献

1
Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system.靶向中枢神经系统中G蛋白门控内向整流钾通道(GIRK通道)的治疗潜力
Pharmacol Ther. 2021 Jul;223:107808. doi: 10.1016/j.pharmthera.2021.107808. Epub 2021 Jan 18.
2
Molecular mechanism of CaCC-A01 inhibiting TMEM16A channel.钙激活氯离子通道 A01 抑制 TMEM16A 通道的分子机制。
Arch Biochem Biophys. 2020 Nov 30;695:108650. doi: 10.1016/j.abb.2020.108650. Epub 2020 Oct 23.
3
Ca/CaM/CaMK signaling is involved in cadmium-induced osteoclast differentiation.
用于活细胞实时氯离子成像的可调谐胞质氯离子指示剂
bioRxiv. 2024 Aug 9:2024.08.08.606814. doi: 10.1101/2024.08.08.606814.
4
Regulation of bone homeostasis: signaling pathways and therapeutic targets.骨稳态的调节:信号通路与治疗靶点
MedComm (2020). 2024 Jul 24;5(8):e657. doi: 10.1002/mco2.657. eCollection 2024 Aug.
5
Engineering approaches to manipulate osteoclast behavior for bone regeneration.用于骨再生的操纵破骨细胞行为的工程学方法。
Mater Today Bio. 2024 Apr 3;26:101043. doi: 10.1016/j.mtbio.2024.101043. eCollection 2024 Jun.
6
Transmembrane proteins with unknown function (TMEMs) as ion channels: electrophysiological properties, structure, and pathophysiological roles.具有未知功能的跨膜蛋白(TMEMs)作为离子通道:电生理特性、结构和病理生理作用。
Exp Mol Med. 2024 Apr;56(4):850-860. doi: 10.1038/s12276-024-01206-1. Epub 2024 Apr 1.
7
Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis.米利森蔺通过靶向细胞外信号调节激酶(ERK)并调节线粒体功能来抑制破骨细胞生成和卵巢切除诱导的骨质疏松症。
J Transl Med. 2023 Nov 22;21(1):839. doi: 10.1186/s12967-023-04706-2.
8
Novel one-pot strategy for fabrication of a pH-Responsive bone-targeted drug self-frame delivery system for treatment of osteoporosis.用于制备pH响应性骨靶向药物自框架递送系统以治疗骨质疏松症的新型一锅法策略。
Mater Today Bio. 2023 Jun 3;20:100688. doi: 10.1016/j.mtbio.2023.100688. eCollection 2023 Jun.
9
ANO10 is a potential prognostic biomarker and correlates with immune infiltration in breast cancer.ANO10是一种潜在的预后生物标志物,与乳腺癌中的免疫浸润相关。
Am J Cancer Res. 2023 May 15;13(5):1845-1862. eCollection 2023.
10
Mechanical stimulation controls osteoclast function through the regulation of Ca-activated Cl channel Anoctamin 1.机械刺激通过调节钙激活氯离子通道 ANO1 控制破骨细胞功能。
Commun Biol. 2023 Apr 13;6(1):407. doi: 10.1038/s42003-023-04806-1.
钙调蛋白/CaMK 信号通路参与镉诱导的破骨细胞分化。
Toxicology. 2020 Aug;441:152520. doi: 10.1016/j.tox.2020.152520. Epub 2020 Jun 6.
4
The Role of Ca-NFATc1 Signaling and Its Modulation on Osteoclastogenesis.钙离子-NFATc1 信号通路在破骨细胞分化中的作用及其调控。
Int J Mol Sci. 2020 May 21;21(10):3646. doi: 10.3390/ijms21103646.
5
Hepatocyte TMEM16A Deletion Retards NAFLD Progression by Ameliorating Hepatic Glucose Metabolic Disorder.肝细胞中跨膜蛋白16A缺失通过改善肝脏葡萄糖代谢紊乱延缓非酒精性脂肪性肝病进展
Adv Sci (Weinh). 2020 Mar 20;7(10):1903657. doi: 10.1002/advs.201903657. eCollection 2020 May.
6
TMEM16A Ca-Activated Cl Channel Regulates the Proliferation and Migration of Brain Capillary Endothelial Cells.跨膜蛋白 16A 钙激活氯离子通道调控脑微血管内皮细胞的增殖和迁移。
Mol Pharmacol. 2020 Jul;98(1):61-71. doi: 10.1124/mol.119.118844. Epub 2020 May 1.
7
Agonism of the TMEM16A calcium-activated chloride channel modulates airway smooth muscle tone.TMEM16A 钙激活氯离子通道激动剂调节气道平滑肌张力。
Am J Physiol Lung Cell Mol Physiol. 2020 Feb 1;318(2):L287-L295. doi: 10.1152/ajplung.00552.2018. Epub 2019 Nov 20.
8
Cl as a bona fide signaling ion.Cl 作为一种真正的信号离子。
Am J Physiol Cell Physiol. 2020 Jan 1;318(1):C125-C136. doi: 10.1152/ajpcell.00354.2019. Epub 2019 Nov 6.
9
Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis.鉴定 ANO1(anoctamin 1)为嗜酸性粒细胞性食管炎中食管上皮细胞增殖的关键驱动因素。
J Allergy Clin Immunol. 2020 Jan;145(1):239-254.e2. doi: 10.1016/j.jaci.2019.07.049. Epub 2019 Oct 21.
10
Niclosamide repurposed for the treatment of inflammatory airway disease.尼克罗米德被重新用于治疗炎症性气道疾病。
JCI Insight. 2019 Aug 8;4(15). doi: 10.1172/jci.insight.128414.